Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Digital Cognition in Multiple Sclerosis [NA]
Completed clinical trial assessing digital cognition in multiple sclerosis with results posted in 2020.
-
FDA approval · 2020-10-22FDA Approved: TIZANIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for tizanidine from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis [Phase 3]
Phase 3 trial investigating methylphenidate, modafinil, and amantadine for fatigue in multiple sclerosis has completed with results posted.
-
FDA approval · 2020-10-14FDA Approved: FINGOLIMOD — Original Application (Zydus Lifesciences Limited)
The FDA approved Fingolimod from Zydus Lifesciences Limited as an Original Application for the treatment of relapsing forms of multiple scle…
-
FDA approval · 2020-10-14FDA Approved: DIMETHYL FUMARATE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' original ANDA for dimethyl fumarate, a generic version of the MS therapy Tecfidera, for relapsing fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-10-09FDA Approved: BACLOFEN — Original Application (Method Pharmaceuticals LLC)
FDA approved an original application for baclofen from Method Pharmaceuticals LLC, making a generic version available.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients [Phase 2]
Phase 2 trial assessing bioequivalence of 20 mg subcutaneous ofatumumab delivered via pre-filled syringe vs autoinjector in adults with rela…
-
FDA approval · 2020-10-06FDA Approved: DIMETHYL FUMARATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic dimethyl fumarate in an original application for the treatment of relapsing forms of multiple sclerosis.
-
FDA label_change · 2020-10-01FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Betaseron (interferon beta-1b) submitted by Bayer to update the product labeling.
-
FDA approval · 2020-09-24FDA Approved: DIMETHYL FUMARATE — Original Application (MSN LABORATORIES PRIVATE LIMITED)
FDA has approved the Original Application for Dimethyl Fumarate by MSN Laboratories Private Limited.
-
FDA approval · 2020-09-24FDA Approved: DIMETHYL FUMARATE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's original ANDA for dimethyl fumarate, authorizing a generic version of the drug.
-
FDA approval · 2020-09-24FDA Approved: DIMETHYL FUMARATE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for dimethyl fumarate (generic) for the treatment of relapsing forms of multiple scle…
-
FDA approval · 2020-09-24FDA Approved: DIMETHYL FUMARATE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC’s generic dimethyl fumarate through an original ANDA submission.
-
FDA approval · 2020-09-24FDA Approved: DIMETHYL FUMARATE — Original Application (Zydus Lifesciences Limited)
The FDA approved Zydus Lifesciences Limited's original application for dimethyl fumarate, enabling a generic version of the MS treatment to …
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis [NA]
Clinical trial update on induction therapy using mitoxantrone and plasmapheresis for aggressive multiple sclerosis has completed with posted…
-
FDA approval · 2020-09-10FDA Approved: DALFAMPRIDINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s supplemental application for dalfampridine.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update for study on visual dysfunction and motor fatigue in multiple sclerosis has completed with results posted.
-
FDA approval · 2020-08-21FDA Approved: VUMERITY — Supplemental Application (Biogen Inc.)
FDA approved Biogen's supplemental application for VUMERITY (diroximel fumarate).
-
FDA approval · 2020-08-14FDA Approved: DALFAMPRIDINE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for dalfampridine from Micro Labs Limited.
-
FDA approval · 2020-08-14FDA Approved: DALFAMPRIDINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for dalfampridine from Sun Pharmaceutical Industries, Inc., indicating an approval related to th…
-
FDA approval · 2020-08-13FDA Approved: TERIFLUNOMIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for teriflunomide from Glenmark Pharmaceuticals Inc., USA, enabling a generic version of the dru…
-
FDA approval · 2020-08-13FDA Approved: BACLOFEN — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Baclofen from Endo USA, Inc. (ANDA077068).
-
FDA approval · 2020-08-13FDA Approved: DALFAMPRIDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for dalfampridine from Aurobindo Pharma Limited, indicating an approval action for this generic prod…
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Theory Based Intervention Program to Support Physical Activity for Individuals With Multiple Sclerosis: a Case Series [NA]
A completed case series evaluating a theory-based intervention program to support physical activity in individuals with multiple sclerosis; …
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study [Phase 2]
Phase 2 randomized trial evaluating stem cell therapy in multiple sclerosis patients who failed other approved therapies; study completed wi…